methyl benzoate has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Güller, P; Kalın, R; Kesebir, AÖ; Küfrevioğlu, Öİ; Özdemir, H | 1 |
| Pavelić, J; Pavelić, K; Pavelić, ZP; Pećina-Slaus, N; Storga, D | 1 |
2 other study(ies) available for methyl benzoate and Benign Neoplasms
| Article | Year |
|---|---|
Methyl benzoate derivatives as inhibitors of pentose phosphate pathway, which promotes cancer progression and drug resistance: An in silico study supported by in vitro results.
Topics: Benzoates; Drug Resistance; Humans; Molecular Docking Simulation; Neoplasms; Pentose Phosphate Pathway | 2022 |
c-fms is present in primary tumours as well as in their metastases in bone marrow.
Topics: Acetone; Benzoates; Bone Marrow Diseases; Female; Gene Expression; Genes, fms; Humans; Leukemia, Myeloid, Acute; Neoplasm Metastasis; Neoplasms; Xylenes | 1992 |